JW Pharmaceutical Corp (001065) — Long-term Investment Intensity
JW Pharmaceutical Corp (001065) has a Long-term Investment Intensity of 0.9% as of December 2019. Long-term investments of ₩5.23 Billion represent 0.9% of total assets of ₩573.21 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check asset resilience ratio of JW Pharmaceutical Corp to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
JW Pharmaceutical Corp Long-term Investment Intensity (2014–2019)
This chart shows how JW Pharmaceutical Corp's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2019. As of December 2019, the intensity stands at 0.9%, reflecting long-term investments of ₩5.23 Billion against total assets of ₩573.21 Billion KRW. For the complete balance sheet picture, see balance sheet size of JW Pharmaceutical Corp.
Annual Long-term Investment Intensity for JW Pharmaceutical Corp (2014–2019)
The table below presents the year-by-year Long-term Investment Intensity for JW Pharmaceutical Corp from 2014 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read JW Pharmaceutical Corp total liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 0.9% | ₩5.23 Billion | ₩573.21 Billion | ▼ -0.6 pp |
| 2018 | 1.5% | ₩8.91 Billion | ₩593.79 Billion | ▲ +0.9 pp |
| 2017 | 0.6% | ₩3.94 Billion | ₩630.87 Billion | ▲ +0.1 pp |
| 2016 | 0.5% | ₩3.39 Billion | ₩651.08 Billion | ▼ -0.3 pp |
| 2015 | 0.9% | ₩5.24 Billion | ₩613.48 Billion | ▲ +0.0 pp |
| 2014 | 0.9% | ₩5.01 Billion | ₩589.24 Billion | — |